Health Highlights, April 7, 2022
Is the CDC in crisis? Former agency heads debate its future. A handful of former directors say they support a sweeping review of the agency that's been ordered up by current director Dr. Rochelle Walensky. Read more
Experimental pill may fight antibiotic-resistant UTIs. The new pill, called tebipenem HBr, worked as well as a standard IV antibiotic in treating patients hospitalized with "complicated" UTIs, a study has found. Read more
Upped risk for clots lasts at least 6 months after COVID. A new study suggests that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding, researchers say. Read more
U.S. nursing home industry needs an overhaul. A major new report finds facilities awash in ineffective care and staffing shortages. Its authors call for sweeping changes in an industry whose failures have only been exacerbated by the pandemic. Read more
Are retooled COVID booster shots coming this fall? Federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin by next month, and a final formula chosen by June. Read more
Related Posts
En la cirugía para el cáncer de pulmón en etapa temprana, menos quizá sea más
VIERNES, 10 de febrero de 2023 (HealthDay News) -- Algunos pacientes que se...
Modified Child-Turcotte-Pugh Score Performs Well in Decompensated Cirrhosis
FRIDAY, May 5, 2023 (HealthDay News) -- A modified Child-Turcotte-Pugh (aCTP)...
Muchos sobrevivientes a un ACV sufren arritmias cardiacas persistentes
JUEVES, 9 de febrero de 2023 (HealthDay News) -- Alrededor de un 20 por ciento...
Los casos de ómicron superan al máximo de la delta en EE. UU., pero con menos hospitalizaciones
LUNES, 27 de diciembre de 2021 (HealthDay News) -- La COVID-19 vuelve a...